feed,title,long_url,short_url
SeekingAlpha,Entera Bio completes enrollment in Phase 2 trial of EB613 in Osteoporosis,https://seekingalpha.com/news/3633700,
SeekingAlpha,Xtra-Gold Resources reports Q3 results,https://seekingalpha.com/news/3633698,
SeekingAlpha,"Clarivate divests Techstreet, to a new for-profit subsidiary of ASME",https://seekingalpha.com/news/3633697,
